Allergy Potential of Omeza Collagen Matrix in Human Subjects Using

Updated 04/16/2024

Status Completed

Clinical Trial Summary

Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04510376
Study type	Interventional
Source	Omeza, LLC
Contact
Status	Completed
Phase	N/A
Start date	November 14, 2019
Completion date	November 14, 2019

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04058743` - Nickel Sensitivity	N/A
	Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
	Not yet recruiting	`NCT06065137` - Standardised Drug Provocation Testing in Perioperative Hypersensitivity	Phase 4
	Active, not recruiting	`NCT05605795` - Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test
	Completed	`NCT05185479` - Analysis of Adverse Events in Anesthesia Using Artificial Intelligence
	Recruiting	`NCT05185362` - Epidemiology of Pecan Nut Allergy
	Completed	`NCT03489694` - Repeatability and Reproducibility of Skin Test Endpoint Titration
	Completed	`NCT03525496` - Interest of Challenge Tests for Diagnosis of Immediate Hypersensitivity Against Iodinated Contrast Agents
	Completed	`NCT03942692` - What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
	Enrolling by invitation	`NCT05670756` - Preoperative Survey to Evaluate Patient Allergy
	Recruiting	`NCT05462444` - Development of Personalized Balanced Nutrition Concept Through an IT Platform
	Not yet recruiting	`NCT05284253` - Is There an Allergy to Pure Metallic Gold Microparticles?	N/A
	Completed	`NCT03157505` - Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis	Phase 3
	Completed	`NCT01436617` - Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab	Phase 2
	Not yet recruiting	`NCT05533385` - Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.	N/A
	Not yet recruiting	`NCT05532566` - Quercus Ilex and Quercus Robur Allergen Extracts Standardisation	N/A
	Recruiting	`NCT06011603` - Prineo Sensitivity Dressing Study	Phase 4
	Completed	`NCT04761822` - COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations	Phase 2
	Recruiting	`NCT05367531` - Assessment of Injectable Medication Platforms	N/A